ArticleBioprocess and biosystems engineering2026
One-step immobilization of mutant TvDAAO yields an active and stable biocatalyst in extreme conditions.
Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
D-Amino acid oxidase (DAAO) is an important enzyme in modern biotechnology, used for synthetic, analytical, and medical purposes. Numerous mutant forms of DAAO with different properties have been described previously. Recently, we combined six beneficial amino acid substitutions in DAAO from Trigonopsis variabilis (TvDAAO) to create the multipoint mutant TvDAAO E32R/F33D/F54S/C108F/M156L/C298N (mut-TvDAAO). Compared to the wild-type TvDAAO, the new mutant enzyme showed a fourfold higher catalytic constant in the oxidation of cephalosporin C, an eightfold higher stability against hydrogen peroxide oxidation, and a twentyfold greater thermal stability. In the present work, we demonstrate a one-step immobilization procedure of mut-TvDAAO on strong anion exchange beads Sepabeads EC-QA, yielding an immobilized biocatalyst with enhanced resistance to thermal, oxidative, alkaline, and aeration-induced stress. After immobilization, mut-TvDAAO retains approximately 40% of its initial activity even after incubation for 5 h at 90 °C. Immobilized mut-TvDAAO (imm-mut-TvDAAO) retains approximately 20% of its initial activity in the presence of 0.1 M hydrogen peroxide after 5 h of incubation. The immobilized enzyme remains fully active after 5 h of incubation at pH 13.0. Importantly, immobilization improves catalyst performance under intensive oxygen aeration required for cephalosporin C oxidation, and the activity of imm-mut-TvDAAO does not decrease over 10 consecutive cycles of use. These results show that simple carrier-based immobilization of an engineered TvDAAO variant provides an operationally robust biocatalyst for oxidative transformations under process-relevant stress conditions.
Indexed as
Identifiers
42440129What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.